Notes: |
|
|
|
|
|
|
|
|
|
| ||||||||||
(1) We define operating margin as gross margin less research and development and selling, general and administrative expenses, as presented above. This presentation differs from income from operations as defined by U.S. Generally Accepted Accounting Principles ("GAAP"), as it excludes the effect of compensation associated with the deferred compensation plan obligations. Since the effect of compensation associated with our deferred compensation plan obligations is offset by losses/(gains) from related securities, we believe this presentation provides a more meaningful representation of our ongoing operating performance. A reconciliation of operating margin to income from operations follows: | ||||||||||||||||||||
|
|
|
|
| ||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended | ||||||||||||||||
(In thousands, except per share amounts) |
|
September 28, 2012 |
|
June 29, 2012 |
|
September 30, 2011 |
|
September 28, 2012 |
|
September 30, 2011 | ||||||||||
Operating margin (non-GAAP) |
|
$ |
177,154 |
|
|
$ |
159,364 |
|
|
$ |
205,420 |
|
|
$ |
453,355 |
|
|
$ |
689,118 |
|
Compensation (gain) expense — deferred compensation plan |
|
3,274 |
|
|
(2,313) |
|
|
(6,642) |
|
|
6,697 |
|
|
(4,926) |
| |||||
Income from operations (GAAP) |
|
$ |
173,880 |
|
|
$ |
161,677 |
|
|
$ |
212,062 |
|
|
$ |
446,658 |
|
|
$ |
694,044 |
|
ALTERA CORPORATION | ||||||||
CONSOLIDATED BALANCE SHEETS | ||||||||
(Unaudited) | ||||||||
|
|
|
|
| ||||
(In thousands, except par value amount) |
|
September 28, 2012 |
|
December 31, 2011 | ||||
|
|
|
|
| ||||
Assets |
|
|
|
| ||||
Current assets: |
|
|
|
| ||||
Cash and cash equivalents |
|
$ |
2,849,829 |
|
|
$ |
3,371,933 | |
Short-term investments |
|
144,195 |
|
|
65,222 | |||
Total cash, cash equivalents, and short-term investments |
|
2,994,024 |
|
|
3,437,155 | |||
Accounts receivable, net |
|
348,273 |
|
|
232,273 | |||
Inventories |
|
157,848 |
|
|
122,279 | |||
Deferred income taxes — current |
|
65,223 |
|
|
58,415 | |||
Deferred compensation plan — marketable securities |
|
58,151 |
|
|
54,041 | |||
Deferred compensation plan — restricted cash equivalents |
|
18,524 |
|
|
17,938 | |||
Other current assets |
|
42,134 |
|
|
52,710 | |||
Total current assets |
|
3,684,177 |
|
|
3,974,811 | |||
Property and equipment, net |
|
200,172 |
|
|
171,721 | |||
Long-term investments |
|
685,945 |
|
|
74,033 | |||
Deferred income taxes — non-current |
|
23,047 |
|
|
26,629 | |||
Other assets, net |
|
49,519 |
|
|
35,074 | |||
Total assets |
|
$ |
4,642,860 |
|
|
$ |
4,282,268 | |
|
|
|
|
| ||||
Liabilities and stockholders' equity |
|
|
|
| ||||
Current liabilities: |
|
|
|
| ||||
Accounts payable |
|
$ |
45,589 |
|
|
$ |
52,154 | |
Accrued liabilities |
|
39,183 |
|
|
34,029 | |||
Accrued compensation and related liabilities |
|
43,563 |
|
|
78,181 | |||
Deferred compensation plan obligations |
|
76,675 |
|
|
71,979 | |||
Deferred income and allowances on sales to distributors |
|
400,351 |
|
|
279,876 | |||
Credit facility |
|
— |
|
|
500,000 | |||
Total current liabilities |
|
605,361 |
|
|
1,016,219 | |||
Income taxes payable — non-current |
|
261,843 |
|
|
263,423 | |||
Long-term debt |
|
500,000 |
|
|
— | |||
Other non-current liabilities |
|
9,496 |
|
|
8,730 | |||
Total liabilities |
|
1,376,700 |
|
|
1,288,372 | |||
Stockholders' equity: |
|
|
|
| ||||
Common stock: $.001 par value; 1,000,000 shares authorized; outstanding - 320,563 shares at September 28, 2012 and 322,054 shares at December 31, 2011 |
|
321 |
|
|
322 | |||
Capital in excess of par value |
|
1,107,614 |
|
|
1,050,752 | |||
Retained earnings |
|
2,151,627 |
|
|
1,942,955 | |||
Accumulated other comprehensive income (loss) |
|
6,598 |
|
|
(133) | |||
Total stockholders' equity |
|
3,266,160 |
|
|
2,993,896 | |||
Total liabilities and stockholders' equity |
|
$ |
4,642,860 |
|
|
$ |
4,282,268 | |
|
|
|
|
|
ALTERA CORPORATION | |||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
(Unaudited, in thousands) | |||||||
| |||||||
|
Nine Months Ended | ||||||
|
September 28, 2012 |
|
September 30, 2011 | ||||
|
|
|
| ||||
Cash Flows from Operating Activities: |
|
|
| ||||
Net income |
$ |
436,002 |
|
|
$ |
624,100 | |
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| ||||
Depreciation and amortization |
26,426 |
|
|
23,443 | |||
Stock-based compensation |
70,790 |
|
|
59,983 | |||
Deferred income tax benefit |
(3,367) |
|
|
(9,549) | |||
Tax effect of employee stock plans |
14,381 |
|
|
26,077 | |||
Excess tax benefit from employee stock plans |
(20,790) |
|
|
(22,959) | |||
Changes in assets and liabilities: |
|
|
| ||||
Accounts receivable, net |
(116,000) |
|
|
(23,228) | |||
Inventories |
(35,569) |
|
|
12,496 | |||
Other assets |
5,478 |
|
|
47,986 | |||
Accounts payable and other liabilities |
(34,670) |
|
|
(40,004) | |||
Deferred income and allowances on sales to distributors |
120,475 |
|
|
11,115 | |||
Income taxes payable |
(650) |
|
|
30,122 | |||
Deferred compensation plan obligations |
(2,001) |
|
|
(345) | |||
Net cash provided by operating activities |
460,505 |
|
|
739,237 | |||
Cash Flows from Investing Activities: |
|
|
| ||||
Purchases of property and equipment |
(53,712) |
|
|
(23,178) | |||
Sales of deferred compensation plan securities, net |
2,001 |
|
|
345 | |||
Purchases of available-for-sale securities |
(819,662) |
|
|
(130,146) | |||
Proceeds from sale and maturity of available-for-sale securities |
135,650 |
|
|
1,750 | |||
Purchases of intangible assets |
(2,280) |
|
|
— | |||
Purchases of other investments |
(4,510) |
|
|
— | |||
Net cash used in investing activities |
(742,513) |
|
|
(151,229) | |||
Cash Flows from Financing Activities: |
|
|
| ||||
Proceeds from issuance of common stock through various stock plans |
37,514 |
|
|
93,619 | |||
Shares withheld for employee taxes |
(30,529) |
|
|
(31,122) | |||
Payment of dividends to stockholders |
(83,570) |
|
|
(64,328) | |||
Proceeds from issuance of long-term debt |
500,000 |
|
|
— | |||
Repayment of credit facility |
(500,000) |
|
|
— | |||
Long-term debt and credit facility issuance costs |
(5,244) |
|
|
— | |||
Repurchases of common stock |
(179,057) |
|
|
(197,018) | |||
Excess tax benefit from employee stock plans |
20,790 |
|
|
22,959 | |||
Net cash used in financing activities |
(240,096) |
|
|
(175,890) | |||
Net (decrease) increase in cash and cash equivalents |
(522,104) |
|
|
412,118 | |||
Cash and cash equivalents at beginning of period |
3,371,933 |
|
|
2,765,196 | |||
Cash and cash equivalents at end of period |
$ |
2,849,829 |
|
|
$ |
3,177,314 |